| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Martin Javier San65 | Chief Medical Officer | Sell10b5-1 | 8,303 | $35.26 | $292,803.92 | -4.0% | -26.7% | -44.4% | |
| Jan 5, 2024 | James C Hamilton58 | Chief Discovery/ Trans Medicine | Sell10b5-1 | 38,443 | $34.69 | $1,333,528.95 | -14.9% | -26.7% | -44.4% | |
| Jan 5, 2024 | Patrick O'Brien76 | COO and General Counsel | Sell10b5-1 | 33,190 | $34.36 | $1,140,362.32 | -6.7% | -26.7% | -44.4% | |
| Jan 2, 2024 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 9,952 | $31.01 | $308,636.66 | -0.3% | -8.9% | -36.6% | |
| Dec 20, 2023 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 12,000 | $28.54 | $342,480.00 | -0.3% | -0.2% | -29.9% | |
| Nov 20, 2023 | Martin Javier San65 | Chief Medical Officer | Sell10b5-1 | 19,700 | $28.80 | $567,315.34 | -13.0% | +1.1% | -35.6% | |
| Oct 25, 2023 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 24,338 | $24.21 | $589,222.98 | -0.6% | +43.0% | -16.9% | |
| Sep 28, 2023 | Victoria Vakiener53 | Director | Sell | 1,550 | $26.33 | $40,811.50 | -6.7% | +15.2% | -27.0% | |
| Sep 18, 2023 | Christopher Richard Anzalone60 | Chief Executive Officer | Sale+OE | 57,755 | $28.12 | $1,624,222.64 | -1.5% | -0.7% | -28.9% | |
| Jul 3, 2023 | Tracie Oliver70 | Chief Commercial Officer | Sell | 8,925 | $35.31 | $315,141.75 | -12.7% | -25.4% | -28.4% |